Vimarsana
Biggest News Aggregation in the World

Page 11 - Development Expense News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Expense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Expense Today - Breaking & Trending Today

My Top Under-the-Radar Artificial Intelligence (AI) Growth Stock to Buy Now - Vimarsana News

My Top Under-the-Radar Artificial Intelligence (AI) Growth Stock to Buy Now

At a six-month low, Adobe is looking like a worthy turnaround play.

Source: fool.com
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update - Vimarsana News

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024First patient dosed in new Phase 2 breast cancer prevention studyData from ongoing Phase

Cellectar Biosciences Reports Financial Results for Year - Vimarsana News

Cellectar Biosciences Reports Financial Results for Year

Management to host a conference call today at 8:30 am ET...

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update - Vimarsana News

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

FLORHAM PARK, N.J., March 27, 2024 -- Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the...

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2023. Unless otherwise stated, all comparisons are for the...